Myeloperoxidase Stimulates Neutrophil Degranulation
- Autores: Grigorieva D.V.1, Gorudko I.V.1, Sokolov A.V.2,3, Kostevich V.A.2,3, Vasilyev V.B.2, Cherenkevich S.N.1, Panasenko O.M.3
-
Afiliações:
- Physics Faculty, Belarusian State University
- Institute of Experimental Medicine
- Scientific Research Institute of Physical-Chemical Medicine, Russian Federal Medical-Biological Agency
- Edição: Volume 161, Nº 4 (2016)
- Páginas: 495-500
- Seção: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/237539
- DOI: https://doi.org/10.1007/s10517-016-3446-7
- ID: 237539
Citar
Resumo
Myeloperoxidase, heme enzyme of azurophilic granules in neutrophils, is released into the extracellular space in the inflammation foci. In neutrophils, it stimulates a dose-dependent release of lactoferrin (a protein of specific granules), lysozyme (a protein of specific and azurophilic granules), and elastase (a protein of azurophilic granules). 4-Aminobenzoic acid hydrazide, a potent inhibitor of peroxidase activity of myeloperoxidase, produced no effect on neutrophil degranulation. Using signal transduction inhibitors (genistein, methoxyverapamil, wortmannin, and NiCl2), we demonstrated that myeloperoxidase-induced degranulation of neutrophils resulted from enzyme interaction with the plasma membrane and depends on activation of tyrosine kinases, phosphatidylinositol 3-kinases (PI3K), and calcium signaling. Myeloperoxidase modified by oxidative/halogenation stress (chlorinated and monomeric forms of the enzyme) lost the potency to activate neutrophil degranulation.
Sobre autores
D. Grigorieva
Physics Faculty, Belarusian State University
Email: o-panas@mail.ru
Belarus, Minsk
I. Gorudko
Physics Faculty, Belarusian State University
Email: o-panas@mail.ru
Belarus, Minsk
A. Sokolov
Institute of Experimental Medicine; Scientific Research Institute of Physical-Chemical Medicine, Russian Federal Medical-Biological Agency
Email: o-panas@mail.ru
Rússia, St. Petersburg; Moscow
V. Kostevich
Institute of Experimental Medicine; Scientific Research Institute of Physical-Chemical Medicine, Russian Federal Medical-Biological Agency
Email: o-panas@mail.ru
Rússia, St. Petersburg; Moscow
V. Vasilyev
Institute of Experimental Medicine
Email: o-panas@mail.ru
Rússia, St. Petersburg
S. Cherenkevich
Physics Faculty, Belarusian State University
Email: o-panas@mail.ru
Belarus, Minsk
O. Panasenko
Scientific Research Institute of Physical-Chemical Medicine, Russian Federal Medical-Biological Agency
Autor responsável pela correspondência
Email: o-panas@mail.ru
Rússia, Moscow
Arquivos suplementares
